Old Web
English
Sign In
Acemap
>
authorDetail
>
Eva K Roth
Eva K Roth
Heidelberg University
Osteosarcoma
Prexasertib
Clonogenic assay
Cisplatin
Talazoparib
2
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Germline RET variants underlie a subset of paediatric osteosarcoma.
2020
Journal of Medical Genetics
Michal Kováč
Connor Woolley
Sebastian Ribi
Claudia Blattmann
Eva K Roth
Marco Francesco Morini
Monika Kováčová
Baptiste Ameline
Andreas E. Kulozik
Stefan S. Bielack
Wolfgang Hartmann
Mandy L. Ballinger
David M. Thomas
Ian Tomlinson
Michaela Nathrath
Karl Heinimann
Daniel Baumhoer
Show All
Source
Cite
Save
Citations (1)
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib
2019
International Journal of Cancer
Christopher L Heidler
Eva K Roth
Markus Thiemann
Claudia Blattmann
Ramon Lopez Perez
Peter E. Huber
Michal Kovac
Beate Amthor
Gabriele Neu-Yilik
Andreas E. Kulozik
Show All
Source
Cite
Save
Citations (9)
1